:Fixed Point

The news today that AstraZeneca failed to meet phase III trials for its stroke drug NXY-059 has prompted Tim Worstall to ask opponents of drug patents
If AstraZeneca is not allowed to make fat profits from those drugs that do work, do get through phase III trials, where is that money going to come from? Without […]

Bryan Caplan has written a thought provoking paper building on Thomas Szasz’s work to argue that most mental illness can be seen as unusual preferences rather than having a medical or pathological basis. We should not, he says, be surprised by unusual prefernces given the enormous variety of tastes out there.
I am preparing a co-authored […]